Revance Therapeutics, Inc.
Revance Therapeutics, Inc. (RVNC) Market Cap & Net Worth
Live market cap, enterprise value, and global rank — multi-year chart and annual table below.
rvnc · market cap & enterprise value · FMP · as of Feb 6, 2025
Core market cap & key metrics
As of Feb 6, 2025, Revance Therapeutics, Inc. (RVNC) has a market cap — also referred to as its net worth or valuation — of $381,023,500, making it one of the top most valuable companies globally. Market Cap = $3.65 × shares outstanding.
Compared to Peers
View Healthcare sectorAbout Market Cap, Net Worth & Valuation
Revance Therapeutics, Inc. (RVNC) has a market cap — also referred to as its net worth or valuation — of $381,023,500 as of Feb 6, 2025, making it the #0 most valuable company globally. Market Cap = Stock Price × Shares Outstanding.
Revance Therapeutics, Inc. reached its all-time high market cap of $0 on —. Comparing the Revance Therapeutics, Inc. market cap history illustrates one of the most extraordinary corporate growth stories.
Investors frequently compare Revance Therapeutics, Inc. net worth vs peers and ask how Revance Therapeutics, Inc. valuation compares to other countries. Its market cap reflects continued investor confidence.
Frequently Asked Questions
RVNC market cap · 6 questionsRevance Therapeutics, Inc.'s net worth — measured as market capitalization — is $381,023,500 as of Feb 6, 2025. It ranks #0 globally. Market Cap = $$3.65 (price) × shares outstanding.